CompletedPhase 4

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Egypt158 participantsStarted 2025-08-01

Plain-language summary

People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute inferior ST elevation myocardial infarction Exclusion Criteria: * Execution of rescur percutaneous coronary intervention after thrombolysis * Mechanical complications or no reflow or spontaneous reperfusion. * Prior implantation of permanent or temporary pacemakers * History of bradycardia, hypotension or ventricular tachycardia with a definitive cause (unrelated to the disease under study) * Prior coronary artery bypass graft surgery * Atropine contraindications Unwillingness to participate in the

What they're measuring

Conduction abnormalities

Timeframe: Periprocedurally

Reperfusion arrhythmias

Timeframe: Periprocedurally

Trial details

NCT IDNCT07268586

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-28

View on ClinicalTrials.gov More Myocardial Infarction trials